Le Lézard
Classified in: Health
Subject: ACC

Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm


UPPSALA, Sweden, May 10, 2024 /PRNewswire/ -- On March 28, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO: ORX) (OTCQX: ORXOY) successfully issued senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "Bonds").

Pursuant to the terms and conditions for the Bonds, Orexo has undertaken to apply for admission to trading of the Bonds on the sustainable bond list of Nasdaq Stockholm. For this purpose, the Company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the Company's website www.orexo.com and at the Swedish Financial Supervisory Authority's website www.fi.se. The application for admission to trading has been submitted and the first day of trading of the Bonds is estimated to be around May 14, 2024.

For further information please contact:
Nikolaj Sørensen, President and CEO
Fredrik Järrsten, EVP and CFO
Lena Wange, IR & Communications Director
Tel: +46 (0)18 780 88 00
E-mail: [email protected]

About Orexo
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.

For more information about Orexo please visit www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube.

The information was sent for publication, through the agency of the contact person set out above, on May 10, 2024, at 1.30 pm CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-publishes-prospectus-and-applies-for-admission-to-trading-of-social-bonds-on-nasdaq-stockholm,c3976889

The following files are available for download:

https://mb.cision.com/Main/694/3976889/2788792.pdf

Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm

 

SOURCE Orexo


These press releases may also interest you

at 13:16
Chris Schaefer Appointed as Chief Financial Officer at CAQH
CAQH is pleased to announce the appointment of Chris Schaefer as the new Chief Financial Officer. Chris will also serve as a member of the Executive Leadership Team. In his new role, Chris will be responsible for directing the organization's...

at 13:15
InventHelp Inventor Develops New Set of Smart Support Bands (BRK-4270)
"I wanted to create a new set of smart support bands to monitor a person's movements and muscle expansion/contraction during exercise workouts, athletic training, or simply everyday activities," said an inventor, from Hueytown, Ala., "so I invented...

at 13:12
IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and academic research
Today, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP extract of Tabernanthe iboga available for use in ibogaine clinics and academic research. IBEX011 also marks the first time that an ibogaine product is...

at 13:00
American Academy of Pediatric Dentistry to Honor Outstanding Members
The American Academy of Pediatric Dentistry (AAPD), the leading authority on children's oral health, will celebrate the 2024 winners of its prestigious awards during the organization's Annual Meeting, AAPD 2024, in Toronto from May 24-26....

at 12:51
The Assistant Secretary for Health and members of the President's Council on Sports, Fitness & Nutrition to address the National Press Club at a Headliners event on May 28
On Tuesday, May 28 at 2 pm, the U.S. Department of Health and Human Services (HHS) and members from the President's Council on Sports, Fitness & Nutrition (Council) will discuss the challenges and opportunities to improve the mental health and...

at 12:50
California's Life Science Industry Generates $414.2 Billion Annually
Biocom California, the association representing the California life science industry, today released a new report showing California's life science industry directly provides more than 465,000 jobs in the state and generates $414.2 billion in total...

More news about Health...


News published on and distributed by: